Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

FDA clears IND application for first-in-human study of CPT-31

Dec. 11, 2019

World AIDS Day: Immediate ART initiation for neonates with HIV-1 provides significant benefits

Dec. 2, 2019

Less can be more for HIV vaccines, in several ways

Nov. 27, 2019

ViiV Healthcare synthesizes prodrugs of HIV maturation inhibitors

Nov. 15, 2019

Mologen announces the initiation of phase IIa TITAN combination trial

Nov. 8, 2019

Broad strategy for HIV bnAbs

Nov. 5, 2019

HIV replication inhibitors detailed in ViiV Healthcare patent

Nov. 4, 2019

Convertible CARs to the reservoir rescue?

Oct. 31, 2019

TaiMed Biologics discontinues development of TMB-607

Oct. 28, 2019

Reservoir grows when ART starts

Oct. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...